Withings Announces the FDA Clearance of ScanWatch — Its Most Medically Advanced Hybrid Smartwatch

ScanWatch becomes the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist ISSY-LES-MOULINEAUX, France, Oct. 12, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, is pleased to announce ScanWatch, its globally acclaimed and most medically advanced wearable, […]

Shockwave IVL Consistently Treats “Real World” Calcium Across Multiple Peripheral Vessel Beds

Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions SANTA CLARA, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, […]

mSToPS Clinical Trial Demonstrates Zio by iRhythm Significantly Improves Health Outcomes for At-Risk Patient Populations

Data published in PLOS One shows continuous monitoring leads to earlier diagnosis and prevents adverse cardiac events, furthering the case for cardiac screening SAN FRANCISCO, Oct. 05, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced the results of […]

Tenax Therapeutics Announces Clearance of the Investigational New Drug Application for Imatinib in Pulmonary Arterial Hypertension (PAH)

Unique, Delayed-Release Formulation of Imatinib Designed to Avoid Gastric Intolerance On Track to Initiate a Single Phase 3 in PAH in 2Q 2022 Recently Updated Company Website Highlights Imatinib Clinical Program MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary […]

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiac Electrophysiology

The PURE EP™ System is validated in multi-center study as superior to conventional sources of intracardiac signals Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and […]

Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke

Study Published in JAMA Cardiology Demonstrates a Three-Fold Increased Risk of Ischemic Stroke Within 30 Days of a Multi-Hour AF Event DUBLIN, Oct. 4, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the publication of a study demonstrating, through the use of a Medtronic continuous rhythm monitoring […]

Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

Completion of patient enrolment expected before end of year Primary endpoint read-out due in Q4 2022 59 patients already recruited in the Pivotal Cohort Ghent, Belgium – 4 October 2021 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver […]

Match Health Academy Launches Innovative Video-Based Courses on Atrial Fibrillation (AFib)

SANTA CLARA, Calif., Sept. 30, 2021 /PRNewswire/ — Match Health Academy has launched three online, expert-guided, video-based courses designed to help patients and their families better understand and manage AFib. The three courses offered include: AFib Essentials, The Ultimate Guide to Afib Nutrition and The Ultimate Guide to Yoga for AFib. The courses are designed to […]

Dr. Willcox Presents Study at Heart Rhythm Society: When Reviewing Heart Monitor Data, Human Technicians Outperform Artificial Intelligence by Over 200 Percent

ANCHORAGE, Alaska, Sept. 28, 2021 /PRNewswire/ — A pilot study led by Alaska Heart & Vascular Institute’s (AHVI) electrophysiologist Mark E. Willcox, MD, found that human-led diagnostic data interpretation outperformed artificiual intelligence (AI) screenings by over 200 percent. As a study initially designed to compare the performance of two common cardiac monitors—the BioGuardian by […]

FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring

Innovative Next-Generation Technology Monitors the Most Important Vital Signs for Cardiovascular Health CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform. Continuous […]